ASPEN PHARMACARE HOLDINGS LIMITED - Clarification in Respect of Form of Proxy

Clarification in Respect of Form of Proxy

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")

CLARIFICATION IN RESPECT OF FORM OF PROXY

Shareholders are referred to the no change statement and notice of
annual general meeting (“AGM”) announcement released by the Company on
30 October 2014. Please be advised that the form of proxy attached to
the issued notice of AGM erroneously confirms that the date on which
proxy forms must be returned to the Company’s transfer secretaries as
being 28 November 2014, while the correct return date for proxy forms
is Friday, 5 December 2014 (as accurately reflected on the notice of
AGM).

A revised form of proxy has been posted on the Company’s website
(www.aspenpharma.com) or can be obtained from the Company Secretary
(rverster@aspenpharma.com) should this be required. Both versions of
the form of proxy received before 09:00 on Friday, 5 December 2014
will be accepted and effective at the AGM to be held on Monday,
8 December 2014 at 10:00.

Durban
11 November 2014

Sponsor: Investec Bank Limited

Date: 11/11/2014 05:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.